
Krishna Institute of Medical Sciences Ltd (KIMS) Share Price Falls 3.58% Today
Updated: 4 Aug 2026 • 12:14 pm
Posted by:

Krishna Institute of Medical Sciences Ltd Share Price fell 3.58% to Rs 790.95, with a market cap of Rs 33,789.52 crore.
Krishna Institute of Medical Sciences Ltd Share Price experienced a significant decline today, falling by 3.58% to close at Rs 790.95. This drop from the previous close of Rs 820.3 places the company's market capitalization at Rs 33,789.52 crore. The decline in share price reflects broader market volatility, though specific catalysts for this movement are not evident from the available data.
Today's trading session saw the stock open at Rs 804.85, reaching a high of Rs 822.2 before declining to its closing price. The total volume of shares traded was 636,452, with a turnover of Rs 1.53 crore. This level of activity indicates a strong interest in the stock, despite the downward price movement. The healthcare sector, to which Krishna Institute of Medical Sciences Ltd belongs, is known for its resilience, yet today's performance highlights the challenges faced by companies within this space.
Krishna Institute of Medical Sciences Ltd (KIMS) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 790.95 |
| Previous Close | Rs 820.3 |
| Today's Change | Rs -29.35 (-3.58%) |
| Day Open | Rs 804.85 |
| Day High | Rs 822.2 |
| Day Low | Rs 790.95 |
| Current Volume (BSE) | 19,331 |
| BSE Traded Volume | 19,331 |
| NSE Traded Volume | 6,17,121 |
| Combined NSE + BSE Volume | 6,36,452 |
| Turnover | Rs 1.53 crore |
| Market Capitalisation | Rs 33,789.52 crore |
| Market Cap Category | Large Cap |
Krishna Institute of Medical Sciences Ltd (KIMS) traded at Rs 790.95. versus the previous close of Rs 820.3, a fall of 3.58%. The stock opened at Rs 804.85, reached Rs 822.2, touched Rs 790.95. Reported volume was 19,331.
Krishna Institute of Medical Sciences Ltd (KIMS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 33,789.52 crore |
The healthcare sector is characterized by its resilience and growth potential, driven by increasing demand for medical services and innovations in healthcare technology. Krishna Institute of Medical Sciences Ltd, as part of this sector, benefits from these trends, although it must also contend with regulatory challenges and competitive pressures.
Investors often look at fundamental indicators such as earnings per share (EPS), book value per share, and dividend yield to assess a company's financial health and potential for future growth. While these specific metrics are not available in the current dataset, they remain critical components of a comprehensive fundamental analysis.
Overall, Krishna Institute of Medical Sciences Ltd's fundamentals suggest a robust position within the healthcare sector, although ongoing market dynamics and sector-specific challenges require careful monitoring.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Benchmark Median P/E | 25.83x |
| Benchmark Average P/E | 94.2x |
| Benchmark P/E Range | 3.41x to 3,364.06x |
| Benchmark Median P/B | 1.91x |
| Benchmark Median ROE | 11.07% |
| Benchmark Median ROCE | 13.35% |
| Company Market Capitalisation | Rs 33,789.52 crore |
| Benchmark Median Market Cap | Rs 139.24 crore |
Krishna Institute of Medical Sciences Ltd (KIMS) is classified under sector: Healthcare.
Track today's top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
The healthcare sector, encompassing a wide range of companies, including pharmaceuticals, biotechnology, and medical services, is a vital part of the economy. Krishna Institute of Medical Sciences Ltd operates within this sector, which is characterized by its resilience and growth potential.
According to the sector snapshot, the healthcare sector comprises 198 companies, with a median P/E ratio of 25.83 and an average P/E ratio of 94.2.
The sector's P/B ratio median is 1.91, with an average of 2.56, indicating a range of valuations across companies. The median ROE is 11.07%, and the median ROCE is 13.35%, reflecting the sector's profitability and efficiency metrics.
Krishna Institute of Medical Sciences Ltd's market capitalization of Rs 33,789.52 crore places it among the larger companies in the sector, which has a median market cap of Rs 139.24 crore. This positioning highlights its significant market presence and influence within the healthcare industry.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,931.84 | 0 | 0.76 | -2.89 | -0.26 |
| Hikal Ltd. | HIKAL | 2,731.11 | 0 | 2.37 | 15.22 | 16.15 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,683.28 | 39.39 | 7.98 | 28.21 | 26.35 |
| Panacea Biotec Ltd. | PANACEABIO | 2,580.49 | 0 | 9.08 | 0 | 5.36 |
| Beta Drugs Ltd. | BETA | 2,474.26 | 62.88 | 9.95 | 18.65 | 22.17 |
Krishna Institute of Medical Sciences Ltd (KIMS) has a market capitalisation of Rs 33,789.52 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
In the healthcare sector, Krishna Institute of Medical Sciences Ltd faces competition from several peers. Notable companies include Dishman Carbogen Amcis Ltd., Hikal Ltd., and Kwality Pharmaceuticals Ltd., among others. These companies vary in market capitalization, valuation metrics, and profitability indicators.
For instance, Kwality Pharmaceuticals Ltd. has a P/E ratio of 39.39 and a P/B ratio of 7.98, with an ROE of 28.21% and an ROCE of 26.35%. In contrast, Hikal Ltd. has a P/B ratio of 2.37, with an ROE of 15.22% and an ROCE of 16.15%. These comparisons provide insights into Krishna Institute of Medical Sciences Ltd's competitive positioning within the sector.
Understanding the relative strengths and weaknesses of these peers is essential for investors looking to assess Krishna Institute of Medical Sciences Ltd's market position and growth potential.
Why Investors Are Watching Krishna Institute of Medical Sciences Ltd
Investors are closely monitoring Krishna Institute of Medical Sciences Ltd due to its significant market presence and the recent price fall. The company's position within the healthcare sector, coupled with its valuation metrics and competitive landscape, makes it a focal point for market participants.
- Price action: A 3.58% decline today, closing at Rs 790.95.
- Sector context: Part of the resilient healthcare sector.
- Market cap: Rs 33,789.52 crore, a large-cap company.
- Peer comparison: Competes with notable healthcare companies.
As the healthcare sector continues to evolve, investors should monitor Krishna Institute of Medical Sciences Ltd's strategic responses to market dynamics and regulatory changes.
About Krishna Institute of Medical Sciences Ltd
Krishna Institute of Medical Sciences Ltd is a prominent player in the healthcare sector, providing a range of medical services and healthcare solutions. The company operates hospitals and healthcare facilities, offering services that cater to various medical needs.
With a focus on quality healthcare delivery, Krishna Institute of Medical Sciences Ltd has established itself as a leader in the industry. The company's operations span multiple regions, contributing to its substantial market presence and influence.
As part of the healthcare sector, Krishna Institute of Medical Sciences Ltd benefits from the growing demand for medical services and advancements in healthcare technology. However, it must also navigate challenges such as regulatory compliance and competitive pressures to maintain its market position.
Track Krishna Institute of Medical Sciences Ltd Share Price on Univest
Use Krishna Institute of Medical Sciences Ltd (KIMS) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.
Investors can track Krishna Institute of Medical Sciences Ltd Share Price on Univest to stay updated on live share prices, technical indicators, and fundamental ratios. Univest provides insights into the company's shareholding pattern, 52-week levels, and market trends, helping investors make informed decisions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
How much did Krishna Institute of Medical Sciences Ltd's share price fall today?
Ans. The share price of Krishna Institute of Medical Sciences Ltd fell by 3.58% today, closing at Rs 790.95. The stock moved -3.58% during the session. The intraday range extended from Rs 790.95 to Rs 822.2.
How does Krishna Institute of Medical Sciences Ltd compare to its peers?
Ans. Krishna Institute of Medical Sciences Ltd competes with peers like Kwality Pharmaceuticals Ltd. and Hikal Ltd., with varying market caps and valuation metrics. Comparable listed companies include Dishman Carbogen Amcis Ltd., Hikal Ltd., Kwality Pharmaceuticals Ltd.
What is the P/E ratio of the healthcare sector?
Ans. The median P/E ratio of the healthcare sector is 25.83, with an average of 94.2, reflecting a wide range of valuations. The relevant peer median P/E is 25.83x. The peer average P/E is 94.2x.
What is the average P/B ratio in the healthcare sector?
Ans. The average P/B ratio in the healthcare sector is 2.56, with a median of 1.91, indicating diverse valuations. The relevant peer median P/E is 25.83x. The peer average P/E is 94.2x.
Recent Articles

Kotak India Growth Fund Series I vs ICICI Prudential Value Fund - Series 14: Full Scheme Comparison and Current Status
4 August 2026

Kotak India Growth Fund Series I vs ICICI Prudential Value Fund - Series 5: Full Scheme Comparison and Current Status
4 August 2026

Kotak India Growth Fund Series I vs ICICI Prudential India Recovery Fund - Series 3: Full Scheme Comparison and Current Status
4 August 2026

Kotak India Growth Fund Series I vs ICICI Prudential Value Fund - Series 1: Full Scheme Comparison and Current Status
4 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Kotak India Growth Fund Series I vs ICICI Prudential Value Fund - Series 14: Full Scheme Comparison and Current Status
Kotak India Growth Fund Series I vs ICICI Prudential Value Fund - Series 5: Full Scheme Comparison and Current Status
Kotak India Growth Fund Series I vs ICICI Prudential India Recovery Fund - Series 3: Full Scheme Comparison and Current Status
Kotak India Growth Fund Series I vs ICICI Prudential Value Fund - Series 1: Full Scheme Comparison and Current Status
Kotak India Growth Fund Series I vs ICICI Prudential Equity Savings Fund - Series 1: Full Scheme Comparison and Current Status
Popular this week
Kotak India Growth Fund Series I vs ICICI Prudential Value Fund - Series 14: Full Scheme Comparison and Current Status
Kotak India Growth Fund Series I vs ICICI Prudential Value Fund - Series 5: Full Scheme Comparison and Current Status
Kotak India Growth Fund Series I vs ICICI Prudential India Recovery Fund - Series 3: Full Scheme Comparison and Current Status
Kotak India Growth Fund Series I vs ICICI Prudential Value Fund - Series 1: Full Scheme Comparison and Current Status
Kotak India Growth Fund Series I vs ICICI Prudential Equity Savings Fund - Series 1: Full Scheme Comparison and Current Status

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





